All terms in EFO
| Label | Id | Description |
|---|---|---|
| biotin | CHEBI_15956 | |
| chondromalacia | MONDO_0002342 | [Pathological processes involving the chondral tissue (cartilage).] |
| articular cartilage disorder | MONDO_0003816 | [A disease involving the articular cartilage of joint.] |
| obsolete X chromosome number anomaly | MONDO_0016999 | |
| intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency | MONDO_0014336 | |
| diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome | MONDO_0014335 | |
| severe combined immunodeficiency due to LCK deficiency | MONDO_0014334 | |
| NK-cell enteropathy | MONDO_0016996 | [Natural killer (NK)-cell enteropathy is a benign NK-cell lymphoproliferative disease characterized by minor abdominal symptoms (abdominal pain, diverticulosis, constipation and reflux) due to NK cell-derived lesions in the mucosal layer of the gastrointestinal tract and often mistaken for NK or T-cell lymphoma.] |
| obsolete_tracheal anomaly | Orphanet_156252 | |
| obsolete complex chromosomal rearrangement | MONDO_0016998 | |
| obsolete peeling skin syndrome type B | MONDO_0016992 | |
| generalized peeling skin syndrome type C | MONDO_0016993 | |
| microcephalic osteodysplastic primordial dwarfism types I and III | MONDO_0016994 | [Microcephalic osteodysplastic primordial dwarfism (MOPD) types 1 and 3 are characterized by intrauterine and postnatal growth retardation, microcephaly, facial dysmorphism, skeletal dysplasia, low-birth weight and brain anomalies. Although MOPD types 1 and 3 were originally described as two separate entities on the basis of radiological criteria (notably small differences in pelvic and long bone structure), later reports confirmed that the two forms represent different modes of expression of the same syndrome.] |
| hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | MONDO_0014332 | |
| gluconeogenesis disorder | MONDO_0019225 | [An acquired metabolic disease that is has its basis in the disruption of gluconeogenesis.] |
| Moyamoya disease with early-onset achalasia | MONDO_0014331 | [Moyamoya disease with early-onset achalasia is an exceedingly rare autosomal recessive neurological disorder reported only in a few families so far. It is characterized by the association of early onset achalasia (manifesting in infancy) with severe intracranial angiopathy that is consistent with moyamoya angiopathy in most cases (moyamoya disease). Other variable associated manifestations include hypertension, Raynaud phenomenon, and livedo reticularis.] |
| Moyamoya disease | MONDO_0016820 | [Moyamoya disease (MMD) is a rare intracranial arteriopathy involving progressive stenosis of the cerebral vasculature located at the base of the brain causing transient ischemic attacks or strokes.] |
| genetic gastro-esophageal disease | MONDO_0015617 | |
| Renal pseudohypoaldosteronism type 1 | Orphanet_171871 | |
| obsolete eculizumab, poor response to | MONDO_0014330 |